After a tumultuous ride at the start of the month, Wall Street has regained momentum and extended its longest bull run in history with the S&P 500 and Dow Jones hitting new highs. Notably, the Dow Jones soared to its first record high since late January. This suggests that the stock market is showing strong complacency, shrugging trade war fears.

The optimism is backed by strong earnings and economic growth. The American economy is on a solid growth path. U.S. GDP growth expanded 4.2% annually in the second quarter, representing the fastest pace of growth in nearly four years. The unemployment rate dropped to nearly a two-decade low of 3.9%, while consumer confidence jumped to the highest level since October 2000. Historic tax cuts, higher government spending, and deregulation are fueling growth.

Meanwhile, earnings growth in the second quarter reached its highest level since 2010. The trend of double-digit growth is expected to continue in Q3 as well, per the latest Earnings Trends report.

A rising rate scenario also signals a strengthening economy, which is spurring growth in the stock market. The wave of mergers and acquisitions and record buybacks are adding to the strength.

While there have been winners in many corners of the space, we highlight eight ETFs that have outperformed the market in the year-to-date time frame. These have a strong Zacks ETF Rank #1 (Strong Buy) or 2 (Buy), suggesting that their outperformance may continue for the rest of the year, provided the fundamentals remain intact.

Invesco S&P SmallCap Health Care ETF (PSCH - Free Report) – Up 43.7%

This ETF provides exposure to the healthcare sector of the U.S. small-cap segment, charging 29 bps in annual fees and has amassed $1.3 billion in its asset base. It is home to 69 stocks and sports a Zacks ETF Rank #1 with a High-risk outlook.

Invesco Dynamic Software ETF (PSJ - Free Report) – Up 35.3%

This ETF provides exposure to the software segment of the broader U.S. technology space and holds a small basket of 30 stocks. It charges 63 bps in annual fees and has AUM of $289.6 million. The product has a Zacks ETF Rank #2 with a High-risk outlook.

SPDR S&P Software & Services ETF (XSW - Free Report) – Up 30.8%

This fund also targets the software and services segment and follows the S&P Software & Services Select Industry Index. It holds 127 stocks in its basket, charging 35 bps in annual fees. XSW has accumulated $134.8 million and has a Zacks ETF Rank #2 with a High-risk outlook.

iShares North American Tech-Software ETF (IGV - Free Report) – Up 30.1%

This ETF tracks the S&P North American Technology-Software Index. Holding a basket of 64 securities, the fund charges 47 bps in annual fees and has AUM of $2.1 billion. IGV has a Zacks ETF Rank #2 with a High-risk outlook.

First Trust Dow Jones Internet Index Fund (FDN - Free Report) – Up 29.1%

This fund targets the Internet corner of the broad technology space and follows the Dow Jones Internet Composite Index. It has AUM of $9.5 billion and holds 42 stocks in its basket. Expense ratio comes in at 0.53%. The fund has a Zacks ETF Rank #1 with a High-risk outlook.

iShares U.S. Medical Devices ETF (IHI - Free Report) – Up 28.2%

The fund provides exposure to U.S. companies that manufacture and distribute medical devices by tracking the Dow Jones U.S. Select Medical Equipment Index. In total, the fund holds 55 securities in its basket with AUM of $3 billion. It charges 43 bps in fees per year and has a Zacks ETF Rank #1 with a Medium risk outlook.

Invesco Russell MidCap Pure Growth ETF (PXMG - Free Report) – Up 28%

This fund offers exposure to a mid-cap segment of the broad U.S. stock market by tracking the Russell Midcap Pure Growth Index, holding 97 securities in its portfolio. It has amassed $318.6 million in its asset base and charges 39 bps in annual fees. The product has a Zacks ETF Rank #2 with a Medium risk outlook.

iShares U.S. Healthcare Providers ETF (IHF - Free Report) – Up 26.3%

This ETF follows the Dow Jones U.S. Select Healthcare Providers Index with exposure to 45 companies that provide health insurance, diagnostics and specialized treatment. It has amassed $934.6 million in its asset base and charges 43 bps in annual fees. The fund has a Zacks ETF Rank #2 with a Medium risk outlook.